543499 Stock Overview
Achyut Healthcare Limited engages in manufacturing and sale of pharmaceutical formulations in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Achyut Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹50.80 |
| 52 Week High | ₹60.79 |
| 52 Week Low | ₹34.39 |
| Beta | 1 |
| 1 Month Change | 17.87% |
| 3 Month Change | -9.53% |
| 1 Year Change | -1.93% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 260.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543499 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 13.6% | -0.7% | -1.5% |
| 1Y | -1.9% | 65.7% | 45.0% |
Return vs Industry: 543499 underperformed the Indian Healthcare industry which returned 65.7% over the past year.
Return vs Market: 543499 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 543499 volatility | |
|---|---|
| 543499 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543499 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 543499's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 4 | Jigen Modi | achyuthealthcare.com |
Achyut Healthcare Limited engages in manufacturing and sale of pharmaceutical formulations in India. It offers its products in the form of tablets, capsules, oral liquids, and injectables. The company also deals in APIs, pharmaceutical products, and medical devices.
Achyut Healthcare Limited Fundamentals Summary
| 543499 fundamental statistics | |
|---|---|
| Market cap | ₹854.74m |
| Earnings (TTM) | ₹2.52m |
| Revenue (TTM) | ₹22.91m |
339.6x
P/E Ratio37.3x
P/S RatioIs 543499 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543499 income statement (TTM) | |
|---|---|
| Revenue | ₹22.91m |
| Cost of Revenue | ₹16.66m |
| Gross Profit | ₹6.25m |
| Other Expenses | ₹3.73m |
| Earnings | ₹2.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 27.27% |
| Net Profit Margin | 10.99% |
| Debt/Equity Ratio | 0% |
How did 543499 perform over the long term?
See historical performance and comparison